The pound has shrugged off a massive government defeat in the House of Commons tonight, perhaps because investors see the government’s threat of a no deal Brexit as illusionary given the increasing control over the Brexit process that the legislative body is now taking, affirms the CEO of one of the world’s largest independent financial advisory organisations.
Elasmogen Licenses NDureTM Half-life Extension Technology to ImmunoForge
Novel soloMER based albumin binder will be used for two therapeutic fusion proteins
Aberdeen, Scotland and Seoul, Korea; January 2019: Elasmogen Ltd, developer of next generation soloMER biologics, announces that ImmunoForge has entered a license agreement to Elasmogen’s proprietary NDure half-life extension technology for use in two non-disclosed targets. ImmunoForge will be responsible for all pre-clinical and clinical development as well as for manufacturing and commercialisation of the resulting products. Elasmogen will receive an initial up-front payment in addition to future milestone and royalty payments.
Today, I was on a call with President Trump and other conservative leaders and activists. It was an encouraging call because he reiterated his willingness to stand firm for his broad approach to border security. He thanked everyone for supporting him in this process and asked us to continue to do one thing.
When the breeder told him that he couldn’t sell the tiny pup because of his size and informed him of the horrible plans to shoot the puppy, he took the dog home. Now, the pup has grown up to be big and strong, and has even helped his human mom through her depression.
Our withdrawal from the European Union has reached a critical stage. MPs are breaking every constitutional convention, rule and tradition to thwart a sovereign Brexit mandated directly by the people. Letters have been flooding into Tory associations calling for deselections. Leave.EU is calling upon supporters to do the same.